HYPOGLYCEMIC EFFECT OF SITAGLIPTIN AND AMINOGUANIDINE COMBINATION IN EXPERIMENTAL DIABETES MELLITUS | Kurkin | Pharmacy & Pharmacology

Pharmacy & Pharmacology
Farmaciâ i farmakologiâ

ISSN 2307-9266 (Print)
ISSN 2413-2241 (Online)

eng | рус

Preview

Pharmacy & Pharmacology

Advanced search

Archives

Download this PDF file

For citations:

Kurkin D.V., Bakulin D.A., Morkovin E.I., Gorbunova Yu.V., Strygin A.V., Andriashvili T.M., Sokolova A.A., Bolokhov N.S., Pustynnikov V.E., Fomichev E.A. HYPOGLYCEMIC EFFECT OF SITAGLIPTIN AND AMINOGUANIDINE COMBINATION IN EXPERIMENTAL DIABETES MELLITUS. Pharmacy & Pharmacology. 2022;10(6):536-548. https://doi.org/10.19163/2307-9266-2022-10-6-536-548

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2307-9266 (Print)
ISSN 2413-2241 (Online)

Editor-in-Chief

Petrov V.I.

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

D. V. Kurkin
Volgograd State Medical University
Russian Federation

Doctor of Sciences (Pharmacy), Associate Professor, Professor of the Department of Clinical Pharmacology and Intensive Care, Volgograd State Medical University

1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131

D. A. Bakulin
Volgograd State Medical University
Russian Federation

Candidate of Sciences (Medicine), Senior Researcher, Laboratory of Pharmacology of Cardiovascular Drugs of Research Center for Innovative Medicines, Volgograd State Medical University

1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131

E. I. Morkovin
Volgograd State Medical University
Russian Federation

Candidate of Sciences (Medicine), Associate Professor, Head of the Laboratory of Neuropsychopharmacology of Research Center for Innovative Medicines, Volgograd State Medical University

1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131

Yu. V. Gorbunova
Volgograd State Medical University
Russian Federation

Candidate of Sciences (Medicine), Associate Professor, Department of Clinical Pharmacology and Intensive Care, Volgograd State Medical University

1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131

A. V. Strygin
Volgograd State Medical University
Russian Federation

Candidate of Sciences (Medicine), Associate Professor, Deputy Director of Research Center for Innovative Medicines, Volgograd State Medical University

1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131

T. M. Andriashvili
Volgograd State Medical University
Russian Federation

Research Student, Department of Clinical Pharmacology and Intensive Care, Volgograd State Medical University

1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131

A. A. Sokolova
Volgograd State Medical University
Russian Federation

Research Student, Department of Clinical Pharmacology and Intensive Care, Volgograd State Medical University

1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131

N. S. Bolokhov
Volgograd State Medical University
Russian Federation

Research student, Department of Clinical Pharmacology and Intensive Care, Volgograd State Medical University

1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131

V. E. Pustynnikov
Volgograd State Medical University
Russian Federation

Research student, Department of Clinical Pharmacology and Intensive Care, Volgograd State Medical University

1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131

E. A. Fomichev
Volgograd State Medical University
Russian Federation

Research student, Department of Clinical Pharmacology and Intensive Care, Volgograd State Medical University.

1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131

Notifications